✦ LIBER ✦

Substituted lactam biphenyltetrazoles as angiotensin II mediated antihypertensives

✍ Scribed by W.V. Murray; P. Lalan; A. Gill; D.K.H. Lee; R. Falotico; J.M. Lewis; M.F. Addo; M.P. Wachter

Book ID: 108477114
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 320 KB
Volume: 4
Category: Article
ISSN: 0960-894X
DOI: 10.1016/s0960-894x(01)81127-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The synthesis and biological activity of

The synthesis and biological activity of tetrahydroquinoline angiotensin II antagonists containing a substituted biphenyltetrazole group

✍ Andrew P. Thomas; David A. Roberts; Douglas A. Thomason 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Old antihypertensives as novel antineopl

Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

✍ Hüseyin Abali; Ibrahim H Güllü; Hüseyin Engin; Ibrahim C Haznedaroğlu; Mustafa E 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Reactive oxygen species as mediators of

Reactive oxygen species as mediators of angiotensin II signaling

✍ Kathy K Griendling; Masuko Ushio-Fukai 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Part VI. Nonpeptide angiotensin II recep

Part VI. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives

✍ Carini, David J.; Duncia, John V.; Johnson, Alexander L.; Chiu, Andrew T.; Price 📂 Article 📅 1990 🏛 American Chemical Society 🌐 English ⚖ 941 KB

Advances in antihypertensive therapy: No

Advances in antihypertensive therapy: Non-peptide angiotensin II receptor antagonists as potent therapeutic agents

✍ Julian Smith; Amal Wahhab; John Hondrelis; Renee Ganter; Diana Moore; John M. Ma 📂 Article 📅 1996 🏛 Springer Netherlands 🌐 English ⚖ 301 KB

The development of drugs that selectively block angiotensin receptors has resulted largely from a process of trialand-error medicinal chemistry on an early lead. The new generation of angiotensin antagonists or angiotensin mimetics are essentially devoid of side effects and are set to replace the an

Synthesis of [1-sarcosine,8-O-methylseri

Synthesis of [1-sarcosine,8-O-methylserine]angiotensin II and 1-substituted analogs of [8-threonine]angiotensin II as antagonists of angiotensin II

✍ Khosla, M. C.; Hall, M. M.; Munoz-Ramirez, H.; Khairallah, P. A.; Bumpus, F M.; 📂 Article 📅 1977 🏛 American Chemical Society 🌐 English ⚖ 547 KB